clinical trial · NCT07089888
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Tophaceous GoutAllopurinolDotinurad
brief summary
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.
started
Aug 4, 2025
primary completion
Dec 31, 2027
completion
Dec 31, 2027
last updated
Apr 28, 2026
official title
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol